U.S. markets open in 33 minutes
  • S&P Futures

    3,711.50
    -45.25 (-1.20%)
     
  • Dow Futures

    29,710.00
    -272.00 (-0.91%)
     
  • Nasdaq Futures

    11,350.75
    -191.00 (-1.65%)
     
  • Russell 2000 Futures

    1,738.60
    -19.50 (-1.11%)
     
  • Crude Oil

    89.04
    +0.59 (+0.67%)
     
  • Gold

    1,704.40
    -16.40 (-0.95%)
     
  • Silver

    20.35
    -0.31 (-1.50%)
     
  • EUR/USD

    0.9744
    -0.0052 (-0.53%)
     
  • 10-Yr Bond

    3.8810
    +0.0550 (+1.44%)
     
  • Vix

    30.24
    +1.69 (+5.92%)
     
  • GBP/USD

    1.1115
    -0.0054 (-0.48%)
     
  • USD/JPY

    145.1050
    +0.0370 (+0.03%)
     
  • BTC-USD

    19,625.05
    -605.71 (-2.99%)
     
  • CMC Crypto 200

    446.51
    -16.62 (-3.59%)
     
  • FTSE 100

    6,995.97
    -1.30 (-0.02%)
     
  • Nikkei 225

    27,116.11
    -195.19 (-0.71%)
     

Novavax's Revenue Could Fall Even More -- and It's Actually Good News

·4 min read

Pick your favorite of these adjectives, and it will definitely apply to Novavax's (NASDAQ: NVAX) second-quarter update. What's more, Novavax slashed its full-year revenue guidance. Unsurprisingly, Novavax stock crashed on the atrocious, bad, dismal, horrible news.